These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39073513)

  • 1. Hematological features and alternate diagnoses in critically ill thrombotic antiphospholipid syndrome patients.
    Azoulay LD; Frapard T; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Bréchot N; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Frere C; Quentric P; Moyon Q; Luyt CE; Combes A; Amoura Z; Pineton de Chambrun M
    Clin Rheumatol; 2024 Sep; 43(9):2889-2898. PubMed ID: 39073513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Demoule A; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Combes A; Luyt CE; Amoura Z;
    J Autoimmun; 2019 Sep; 103():102292. PubMed ID: 31253464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
    Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
    J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist Know?
    Moyon Q; Mathian A; Papo M; Combes A; Amoura Z; Pineton de Chambrun M
    Curr Rheumatol Rep; 2024 Jul; 26(7):269-277. PubMed ID: 38652403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Luyt CE; Combes A; Amoura Z
    Chest; 2020 May; 157(5):1158-1166. PubMed ID: 31783015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catastrophic APS in the context of other thrombotic microangiopathies.
    Rodríguez-Pintó I; Espinosa G; Cervera R
    Curr Rheumatol Rep; 2015 Jan; 17(1):482. PubMed ID: 25604575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association?
    Tun NT; Krishnamurthy M; Snyder R
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):214-9. PubMed ID: 25304013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How We Interpret Thrombosis with Thrombocytopenia Syndrome?
    Yamada S; Asakura H
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
    Azoulay LD; Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle F; Raphalen JH; Troger A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Moyon Q; Luyt CE; Kerneis M; Combes A; Amoura Z
    J Autoimmun; 2022 Dec; 133():102908. PubMed ID: 36126365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS").
    Asherson RA
    Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catastrophic antiphospholipid syndrome accompanied by complement regulatory gene mutation.
    Pul S; Gökçe İ; Bodur ED; Güven S; Çiçek N; Sak M; Türkkan ÖN; Filinte D; Pehlivanoğlu C; Sözeri B; Alpay H
    Turk J Pediatr; 2023; 65(2):330-337. PubMed ID: 37114699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Summary of pathophysiology and diagnosis of patients with platelet abnormality].
    Wada H; Asakura H
    Rinsho Byori; 2009 May; 57(5):474-6. PubMed ID: 19522256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
    Asherson RA; Espinosa G; Cervera R; Gómez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martínez-González AL; Ingelmo M; Reverter JC; Font J; Triplett DA
    Ann Rheum Dis; 2005 Jun; 64(6):943-6. PubMed ID: 15897312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.
    Rangel ML; Alghamdi I; Contreras G; Harrington T; Thomas DB; Barisoni L; Andrews D; Wolf M; Asif A; Nayer A
    Lupus; 2013 Jul; 22(8):855-64. PubMed ID: 23722230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.
    Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Maślińska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A
    Front Immunol; 2022; 13():957201. PubMed ID: 36172349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.
    Coppo P; Bengoufa D; Veyradier A; Wolf M; Bussel A; Millot GA; Malot S; Heshmati F; Mira JP; Boulanger E; Galicier L; Durey-Dragon MA; Frémeaux-Bacchi V; Ramakers M; Pruna A; Bordessoule D; Gouilleux V; Scrobohaci ML; Vernant JP; Moreau D; Azoulay E; Schlemmer B; Guillevin L; Lassoued K;
    Medicine (Baltimore); 2004 Jul; 83(4):233-244. PubMed ID: 15232311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catastrophic antiphospholipid syndrome: a clinical review.
    Nayer A; Ortega LM
    J Nephropathol; 2014 Jan; 3(1):9-17. PubMed ID: 24644537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.